The Role of PTEN in Myeloid Malignancies
Open Access
- 1 November 2015
- journal article
- review article
- Published by MDPI AG in Hematology Reports
- Vol. 7 (4) , 5844
Abstract
PTEN deletion in the mouse and in the zebrafish highlights the essential role of this tumor suppressor in the development of myeloid malignancies, in particular acute myeloid leukemia and myeloproliferative disorders. In humans, extensive genetic sequences of myeloid malignancies did not reveal recurrent PTEN mutations and deletions. However, PTEN was shown to be functionally inactivated in several acute myeloid leukemia and chronic myeloid leukemia samples, through both post-trasductional modifications, changes in protein levels and cellular compartmentalization. Notably, non genomic inactivation of PTEN in myeloid malignancies could represent a challenging therapeutic opportunity for these diseases. Targeting those mechanisms that affect PTEN function could indeed promote PTEN reactivation with consequent cancer selective apoptosis induction. In this review we will describe the role of PTEN in the development of myeloid malignancies.Keywords
This publication has 42 references indexed in Scilit:
- Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafishJournal of Hematology & Oncology, 2014
- BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSPLeukemia, 2013
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingCancer, 2011
- Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent MannerCell, 2011
- PTEN is a tumor suppressor in CML stem cells and BCR-ABL–induced leukemias in miceBlood, 2010
- The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML networkNature, 2008
- Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patientsLeukemia, 2005
- Phosphoinositide 3-kinase signaling is essential for ABL oncogene–mediated transformation of B-lineage cellsBlood, 2004
- Phosphatase and tensin homologue phosphorylation in the C‐terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcomeBritish Journal of Haematology, 2003